Cargando…
Cardiotoxicity of immune checkpoint inhibitors: A frequency network meta-analysis
Immune checkpoint inhibitors (ICIs) in combination withother anti-cancer treatments have been approved for a variety of cancers. While the difference in the incidence of cardiovascular adverse events has not been fully investigated. We aimed to assess the the differences in cardiotoxicity among canc...
Autores principales: | Liu, Maobai, Cheng, Xitong, Ni, Ruping, Zheng, Bin, Huang, Shunmin, Yang, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515416/ https://www.ncbi.nlm.nih.gov/pubmed/36189211 http://dx.doi.org/10.3389/fimmu.2022.1006860 |
Ejemplares similares
-
Effects of eHealth Interventions on Quality of Life and Psychological Outcomes in Cardiac Surgery Patients: Systematic Review and Meta-analysis
por: Ni, Ruping, et al.
Publicado: (2022) -
Advances in immune checkpoint inhibitors induced-cardiotoxicity
por: Li, Xiang, et al.
Publicado: (2023) -
Hepatotoxicity of immune checkpoint inhibitors: What is Currently Known
por: Zheng, Caiyun, et al.
Publicado: (2023) -
Cardiotoxicity of immune checkpoint inhibitors
por: Varricchi, Gilda, et al.
Publicado: (2017) -
Cardiotoxicity of Immune Checkpoint Inhibitors
por: Patel, Rushin P., et al.
Publicado: (2021)